The current PE ratio for Prestige Consumer Healthcare stock as of Jun 3, 2026 is 11.56. This is calculated based on the current EPS of $3.93 and the stock price of $45.44 per share. The P/E ratio has a decrease of 29% from the past four quarters average of 16.3.
The average historical PE ratio of Prestige Consumer Healthcare for the last ten years is 17.96. The current PE ratio of 11.56 is 36% below the historical average. Over the past ten years, PBH's PE ratio was at its highest in the Jun 2016 quarter at 42.95, when the stock price was $55.4 and the EPS was $1.29. The lowest value was in the Mar 2018 quarter, when it reached 5.27 with a price of $33.72 and an EPS of $6.4.
Maximum annual increase: 50.12% in 2017
Maximum annual decrease: -87.57% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2026 | 15.08 | -24.22% | $59.27 | $3.93 |
| 2025 | 19.9 | 15.43% | $85.97 | $4.32 |
| 2024 | 17.24 | N/A | $72.56 | $4.21 |
| 2023 | N/A | N/A | $62.63 | -$1.65 |
| 2022 | 12.94 | -3.72% | $52.94 | $4.09 |
| 2021 | 13.44 | 2.99% | $44.08 | $3.28 |
| 2020 | 13.05 | N/A | $36.68 | $2.81 |
| 2019 | N/A | N/A | $29.91 | -$0.69 |
| 2018 | 5.27 | -87.57% | $33.72 | $6.4 |
| 2017 | 42.41 | 50.12% | $55.56 | $1.31 |
| 2016 | 28.25 | -1.19% | $53.39 | $1.89 |
| 2015 | 28.59 | 47.9% | $42.89 | $1.5 |
| 2014 | 19.33 | -2.91% | $27.25 | $1.41 |
| 2013 | 19.91 | -15.71% | $25.69 | $1.29 |
| 2012 | 23.62 | 19.11% | $17.48 | $0.74 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 15.08 | -6.86% | $59.27 | $3.93 |
| Dec 2025 | 16.19 | 5.34% | $61.69 | $3.81 |
| Sep 2025 | 15.37 | -17.23% | $62.4 | $4.06 |
| Jun 2025 | 18.57 | -6.68% | $79.85 | $4.3 |
| Mar 2025 | 19.9 | 9.82% | $85.97 | $4.32 |
| Dec 2024 | 18.12 | 4.32% | $78.09 | $4.31 |
| Sep 2024 | 17.37 | 4.2% | $72.1 | $4.15 |
| Jun 2024 | 16.67 | -3.31% | $68.85 | $4.13 |
| Mar 2024 | 17.24 | N/A | $72.56 | $4.21 |
| Dec 2023 | N/A | N/A | $61.22 | -$1.6 |
| Sep 2023 | N/A | N/A | $57.19 | -$1.62 |
| Jun 2023 | N/A | N/A | $59.43 | -$1.68 |
| Mar 2023 | N/A | N/A | $62.63 | -$1.65 |
| Dec 2022 | 14.87 | 24.12% | $62.6 | $4.21 |
| Sep 2022 | 11.98 | -17.66% | $49.83 | $4.16 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
PBH's current P/E ratio is below the 3, 5 and 10-year averages.
With a P/E of 11.56, PBH is below the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 23.02, Prestige Consumer Healthcare's P/E is 50% lower.
PBH's PE ratio is lower than its peer stocks JNJ and PG. Prestige Consumer Healthcare's current PE ratio of 11.56 is below the average of its peers, which is 23.34.
| Stock name | PE ratio | Market cap |
|---|---|---|
| PBH Prestige Consumer Healthcare Inc | 11.57 | $2.15B |
| CLX Clorox Co | 14.53 | $10.84B |
| PFE Pfizer Inc | 19.61 | $146.42B |
| PG PROCTER & GAMBLE Co | 20.14 | $327.75B |
| NVS Novartis AG | 21.14 | $283.17B |
| ABT Abbott Laboratories | 25.24 | $157.84B |
| JNJ Johnson & Johnson | 26.13 | $549.06B |
| CVS CVS HEALTH Corp | 40.87 | $120.98B |
The price to earnings ratio for PBH stock is 11.56 as of Jun 3, 2026.
The average PE ratio for PBH stock over the past 3 years is 17.17.
The average PE ratio for PBH stock over the past 5 years is 15.96.
In the last ten years, the Jun 2016 quarter recorded the highest quarterly PE ratio at 42.95.
The current price to earnings ratio of PBH is 36% lower than the 10-year historical average.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Jun 3, 2026), Prestige Consumer Healthcare's stock price is $45.44. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $3.93. Therefore, Prestige Consumer Healthcare's P/E ratio for today is 11.56. PE RATIO(11.56) = STOCK PRICE($45.44) / TTM EPS($3.93)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.